Supplementary Figure 1 from Selection of Personalized Patient Therapy through the Use of Knowledge-Based Computational Models That Identify Tumor-Driving Signal Transduction Pathways — Wim Verhaegh (2023) | RDL Network
Supplementary Figure 1 from Selection of Personalized Patient Therapy through the Use of Knowledge-Based Computational Models That Identify Tumor-Driving Signal Transduction Pathways
Preprint 2023 en
Authors
WV
Wim Verhaegh
HO
Henk van Ooijen
MI
Márcia A. Inda
Abstract
1 min read
<p>PDF file - 174KB, Variation of predicted ER pathway activity for sample replicates.</p>
Wim Verhaegh, Henk van Ooijen, Márcia A. Inda, Pantelis Hatzis, Rogier Versteeg, Marcel Smid, John W.M. Martens, John A. Foekens, Paul van de Wiel, Hans Clevers, Anja van de Stolpe
Wim Verhaegh, Henk van Ooijen, Márcia A. Inda, Pantelis Hatzis, Rogier Versteeg, Marcel Smid, John W.M. Martens, John A. Foekens, Paul van de Wiel, Hans Clevers, Anja van de Stolpe
Wim Verhaegh, Henk van Ooijen, Márcia A. Inda, Pantelis Hatzis, Rogier Versteeg, Marcel Smid, John W.M. Martens, John A. Foekens, Paul van de Wiel, Hans Clevers, Anja van de Stolpe
Henk van Ooijen, Márcia A. Inda, Pantelis Hatzis, Rogier Versteeg, Marcel Smid, John W.M. Martens, John A. Foekens, Paul van de Wiel, Hans Clevers, Anja van de Stolpe, Wim Verhaegh
Wim Verhaegh, Henk van Ooijen, Márcia A. Inda, Pantelis Hatzis, Rogier Versteeg, Marcel Smid, John W.M. Martens, John A. Foekens, Paul van de Wiel, Hans Clevers, Anja van de Stolpe
Discussion(0)
No comments yet. Be the first to comment.